EventHealthOctober 23, 2026

Pathos raises $237M Series E at $3B valuation

Read original source →statnews.com

Bristol Myers Squibb led the round, which funds Pathos' expansion from oncology into neurological conditions using new Tempus AI datasets, starting with Alzheimer's. Its Foundry model runs thousands of agents to estimate clinical trial success odds.

1 source

More stories today

Open the live feed